9 Apr 2020 16:22
LEI: 549300Q7EXQQH6KF7Z84
9 April 2020
RTW Venture Fund Limited
Notice of Annual Report
RTW Venture Fund Limited (the "Company") advises that it will publish its Annual Report and Audited Financial Statements for the year ended 31 December 2019 (the "Annual Report") on 22 April 2020.
A video conference for analysts and investors will be held at 2 pm BST / 9 am EST on the day. To register for the event please follow the link or notify RTW Investments, LP, by email at RTWVentureFund@rtwfunds.com.
For Further Information
RTW Investments, LP Stephanie Sirota, Chief Business OfficerAlexandra Taracanova, PhD, Director of Investor Relations Julia Enright, Business Development Associate
Ocorian (Company Secretary) Kevin Smith
| +1 (646) 343 9280
+44 (0) 1481 742 642
|
J.P. Morgan Cazenove William Simmonds Oliver Kenyon James Bouverat (Sales)
Barclays Tom Swerling Andrew Tusa Alwyn Clarke Ryan McCarthy | +44 (0)20 7742 4000
+44 (0)20 7623 2323 |
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading US healthcare investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.
Rtw Biotech (RTW)